U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285408) titled 'Sarcopenia and NMIBC Prognosis Study' on Nov. 30.
Brief Summary: The goal of this observational study is to evaluate whether body composition abnormalities (sarcopenia, myosteatosis, and obesity) and nutritional status influence the risk of recurrence and progression in adult patients with non-muscle-invasive bladder cancer (NMIBC). The main questions it aims to answer are:
Do sarcopenia, myosteatosis, obesity, or malnutrition increase the likelihood of NMIBC recurrence and progression?
Can clinical, laboratory, and CT-derived body composition parameters serve as predictive biomarkers that improve individualized risk stratificatio...